Divi's Laboratories Limited (DIVISLAB) — Financial Results Announcement
Net Profit: ₹87.22
📢 Key Event
Trading window closure announced ahead of audited results
💡 Investor Takeaway
Shareholders must avoid trading during the closed window until results are declared.
Divi's Laboratories announced closure of its trading window effective April 1, 2026, ahead of audited financial results for the quarter and year ended March 31, 2026, with board meeting date to be announced.
📄 View Original Announcement (PDF)
About Divi's Laboratories Limited (DIVISLAB)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Market Cap: ₹1,79,470.03 Cr
P/E: 72.4
ROE: 16.6%
ROCE: 22.1%
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.